​Established in 2001, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 45 countries and regions. With a dedicated team of 501–1,000 employees, it operates GMP-certified facilities in Oman, producing a diverse range of products including tablets, capsules, creams, balms, external liquids, and powder sachets. As a GMP manufacturer, it holds certifications from authorities such as US-FDA, MHRA-UK, TGA-Australia, GCC-DR, and ANVISA-Brazil, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

This CTD dossier owner and manufacturer company is a WHO-GMP certified manufacturer and exporter focused on producing a wide range of formulations including beta-lactam products, effervescents, injections, eye/ear/nasal drops, ointments, veterinary medications, hormones, and food supplements. They target key regions in the Middle East, Africa, and Asia with an emphasis on brand building in export markets. The company holds multiple awards for its product quality and export excellence. Their commitment to quality is reflected in their ISO 9001:2008 certification and they prioritize ethical decision-making and transparency. The broad range of products suggests a focus on both acute and chronic conditions.

This company, based in South Asia, specializes in producing a range of pharmaceutical products catering to various therapy areas, including dermatology, dentistry, and pediatrics. Their product portfolio includes over-the-counter medications, prescription drugs, and medical devices, available in different dosage forms like solids, liquids, and injectables. They have a strong commitment to research and development, with a focus on creating innovative products. The company has earned industry recognition for its high-quality products and responsible business practices. They hold GMP (Good Manufacturing Practice) approvals for production in both the European Union and the United States, demonstrating a strong adherence to international standards. The company has been operating in the market for over two decades, solidifying its position as a reliable provider of healthcare solutions.